A study using massive biobank databases has revealed associations between gastrointestinal tract disorders and the neurodegenerative diseases Alzheimer’s and Parkinson’s, and has characterized their genetic and proteomic links. The post Gut Disorders Linked with Alzheimer’s and Parkinson’s Neurodegeneration appeared first on Inside Precision Medicine.| Inside Precision Medicine
Transdermal estradiol, (E2) given with either patches or gels, was associated with better memory of words or events, while oral administration of estradiol was linked with improved prospective memory, or remembering to do things in the future. The post Estradiol Delivery Method Tied to Memory Differences After Menopause appeared first on Inside Precision Medicine.| Inside Precision Medicine
A first-in-human trial testing a novel allogeneic synthetic TCR and antigen receptor (STAR) T cell therapy has shown encouraging early results in patients with severe, treatment-resistant systemic lupus erythematosus (SLE). The post STAR T, An Allogeneic CAR T Alternative, Is Effective in Lupus Patients appeared first on Inside Precision Medicine.| Inside Precision Medicine
Measuring acoustic emissions from microbubbles during focused ultrasound may help researchers standardize blood-brain barrier opening during glioma treatment. The post Glioma Treatment May Benefit from Acoustic Biomarker–Guided BBB Opening appeared first on Inside Precision Medicine.| Inside Precision Medicine
Tamoxifen fuels uterine cancer by activating the PI3K pathway, according to a new study, bypassing mutations normally required. Findings point to potential strategies to reduce risk while preserving the drug’s breast cancer benefits. The post How Tamoxifen Raises Uterine Cancer Risk—and a Path to Prevention appeared first on Inside Precision Medicine.| Inside Precision Medicine
Triple-negative breast cancer in this population was largely similar to that of Asian American and non-Hispanic white women. The post Triple-Negative Breast Cancer Mutations Mapped in Black Women appeared first on Inside Precision Medicine.| Inside Precision Medicine
The research used CRISPR/Cas9 to develop an in vivo screen of MYC-driven lymphoma in mouse models to show that the loss of NPRL3, DEPDC5, or NPRL2 in the GATOR1 complex significantly accelerates lymphoma development. The post CRISPR Screen Identifies GATOR1 as Lymphoma Tumor Suppressor appeared first on Inside Precision Medicine.| Inside Precision Medicine
Implanting donor heart valves in children with congenital heart disease can be safe and effective and reduces the number of operations children need as they grow, research shows. The post Transplanting Heart Valves Effective Option for Congenital Heart Disease appeared first on Inside Precision Medicine.| Inside Precision Medicine
PGT-A for women 35 to 42, a group that has a higher risk of producing embryos with chromosomal abnormalities, could improve IVF success.| Inside Precision Medicine
Teal Health has announced the launch of their Teal Wand at-home cervical cancer screening kit and virtual telehealth services in California.| Inside Precision Medicine
The device detects infection via temperature, pH, and inflammation markers such as C-reactive protein (CRP) and interleukin-6 (IL-6).| Inside Precision Medicine
Takeaways from ECOG-ACRIN trials presented at the 2025 American Society of Clinical Oncology Annual Meeting| ECOG-ACRIN Advocacy Blog
AI model outperforms cardiologists in detecting hidden structural heart disease from routine ECGs, advancing early screening.| Inside Precision Medicine
The allogeneic Azer-cel showed impressive response rates in a Phase Ib study with DLBCL patients who had failed autologous CAR T cell therapy treatments.| Inside Precision Medicine
Mapping blood stem cell metabolism reveals choline as a key nutrient to preserve stem cell health and guide precision therapies.| Inside Precision Medicine
Long-term obesity may trigger aging molecular signals in young adults including epigenetic modifications and telomere shortening, researchers have discovered.| Inside Precision Medicine
Researchers and policymakers in Asia are trying to make medical research more inclusive to better serve the region’s diverse communities.| Asian Scientist Magazine
Partnership with Japan’s Toshiba ESS-DK Medical Solutions consortium The post Asan Medical Center to Open Korea’s Largest Heavy Ion Radiotherapy Facility by 2031 appeared first on Medical Travel Market.| Medical Travel Market
Dr. Marco Marra (Michael Smith Laboratories, Department of Medical Genetics), through his role as the Terry Fox Leader in Cancer Genome Science, played a key role in announcing the ‘Finish […]| Welcome | Michael Smith Laboratories
ISB researchers Drs. Matt Wall, Serdar Turkarslan, Nitin Baliga, and others, along with collaborators, have developed a technology to generate a patient-specific disease-relevance network map to accurately predict risk, personalize therapies, and discover novel drug targets for solid and liquid tumors. The post Baliga Lab researchers and collaborators found that genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma appeared first on Baliga Lab.| Baliga Lab
Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about.| Labiotech.eu
Discover how multivariate analysis is transforming target identification in cancer drug discovery by moving beyond traditional methods.| Labiotech.eu